Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
International Journal of Clinical Oncology|June 15, 2022
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysisYusuke Ozeki, Naoya Kanogawa, Sadahisa Ogasawara, et al.
Liver Cancer|October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular CarcinomaSusumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Cancer Medicine|February 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular CarcinomaMasanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara, et al.
Case Reports in Oncology|December 11, 2023
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular CarcinomaRyoi Yoshida, Keisuke Koroki, Hirokazu Makishima, et al.
Liver Cancer|October 21, 2020
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical TrialsKeisuke Koroki, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
BMJ Open|April 9, 2022
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Scientific Reports|March 6, 2021
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinomaHiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytesHiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 24, 2021
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironmentShohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH StudyKazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Pageof 16